Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Maxindo Karya Anugerah Tbk. (MAXI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Maxindo Karya Anugerah Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Maxindo Karya Anugerah Tbk. trades at Rp50 (market cap 480.5B, 46.4K 24h volume). The key difference: Maxindo Karya Anugerah Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 46.4K). Which is the better fit depends on your goals.
| DGNS | MAXI | |
|---|---|---|
Market Cap | 310.75B | 480.5B |
Volume | 963.6K | 46.4K |
Lot | 9.64K | 464 |
Turnover | 217.67M | 2.32M |
Average Price | 225.89 | 50 |
Value | 217.67M | 2.32M |
Indicative Equilibrium Price | 226 | 50 |
Indicative Equilibrium Volume | 1K | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Maxindo Karya Anugerah Tbk.
PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Read more on MAXI →
